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We are much interested in the article by Shahmoradi et al. pub-
lished in the Journal of Hepatology [1]. In the cross-sectional
report, the authors investigated the serum samples of 75 children
born to hepatitis B surface antigen (HBsAg)-positive mothers.
Hepatitis B virus (HBV) DNA could be detected in 21 (28%) out
of 75 children previously immunized by a dose of HBIG and three
standard injections of hepatitis B vaccines. All were positive for
antibody to hepatitis B surface antigen (anti-HBs), while only 5
(24%) were positive for antibody to hepatitis B core antigen
(anti-HBc). There are some issues to be addressed.
Almost all babies who acquired HBV infection through perina-
tal transmission were born to mothers with positive hepatitis B e
antigen (HBeAg) [2]. HBeAg can cross the placenta and help
establish the infectivity [3]. HBeAg, viral load, and metabolic
factors may entangle each other to foster the perinatal transmis-
sion [4]. However, this article did not elucidate the association
between the risk of occult HBV infection and these three factors.
The relatively higher prevalence of occult HBV infection in this
study is not consistent with our ﬁndings in Taiwan [5], where the
prevalence of occult HBV infection was about 0.1% (3/2954)
under the 25-year infant universal vaccination program coverage.
One possible explanation is that the polymerase chain reaction
used in this report was too sensitive to avoid false positive results
[1]. Besides, the detection of HBV DNA in this study might be too
early for anti-HBc levels to be measurable [6]. HBV genotyping is
another concern. Occult HBV infection in Taiwan is mainly geno-
type C [5], rather than genotype D as in North of Iran [1]. We also
do not know how long the positive HBV DNA status would persist
in these cases.
We agree that mother-to-infant transmission is not com-
pletely blocked by immunoprophylaxis [7]. Although the emerg-
ing escape mutants caused some concern, less infectivity of
G145R, recombinant vaccine use, and mutant loss with older
age seem to decrease the mutant prevalence in an immunized
population over time [8]. In addition to the risk of transmission
by blood transfusion, individuals with occult HBV infection are
at risk of reactivation when they receive chemotherapy or immu-
nosuppressive therapy [6]. However, whether the clinical out-
come of occult HBV infection is signiﬁcant or not remains
unclear since most people with occult HBV infection have a
normal liver function.Reply to: ‘‘Obscure clinical imp
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To the Editor:
We highly appreciate the valuable comments addressed by
Chiang and Ni about our study [1]. The authors highlighted two
major points: ﬁrstly, the correlation between maternal metabolic
Journal of Hepatology 2012In conclusion, a long-term follow-up study is mandatory to
deﬁne the clinical signiﬁcance of occult HBV infection caused
by perinatal transmission if any.
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and HBV status with the infected children and secondly, the high
prevalence of OBI in our study.
Regarding the former, the ﬁles of all mothers and infected
children showed that only 7 (9.3%) out of 75 mothers were HBeAg
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positive. There was no correlation between maternal HBeAg and
anti-HBe positive in terms of demography, serology, and viral
kinetics (as mentioned in the Results section). Only one out of
76 children was HBsAg positive and was excluded from the study.
The metabolic factors were not considered in our survey.
Regarding Ni’s comments on the high prevalence of OBI in our
study, reports by Alavian et al., revealed the prevalence of HBV in
Iran in the range of 1.7% and 2.5% in the general population [2].
However, the prevalence of occult HBV infection in children born
to HBV positive mothers was high (28%) in our study.
Different studies have been carried out in South-East Asia
after EPI (expanded program on immunization) on HBsAg posi-
tive children born to HBsAg positive mothers [3–5]. The surface
protein mutants within or outside of ‘‘a’’ determinant were in
association with a low frequency. In fact, in most of the studies
on EPI, HBV DNA analysis has not been carried out on HBsAg neg-
ative cases to address the prevalence of OBI in this high-risk
individuals.
On the other hand, in the Mu’s study from Taiwan, authors
found prevalence of OBI in vaccinated children (without such
familial history) to be around 10.9%.
In our opinion, these contradictory results might be related to
the technical differences and the levels of sensitivity of the tests
(methods for extraction and ampliﬁcation, etc.), the geographical
distribution of HBV infection, and the genotypic nature of the virus
(genotype D in Iran, and genotypes B and C from South-East Asia).
We believe that additional studies in large cohorts of patients
with long-term clinical and laboratory follow-up are warranted
to better understand the biological basis and signiﬁcance of
occult HBV infection and its consequences after HBV vaccination.
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